These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 12072542)

  • 1. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.
    Hlatky L; Hahnfeldt P; Folkman J
    J Natl Cancer Inst; 2002 Jun; 94(12):883-93. PubMed ID: 12072542
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
    Oklu R; Walker TG; Wicky S; Hesketh R
    J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis pathway inhibitors.
    Herbst RS; LoRusso P; Isobe T; Hurwitz HI
    Cancer Chemother Biol Response Modif; 2005; 22():225-45. PubMed ID: 16110614
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rationale of antiangiogenic therapy].
    Tímár J; Paku S; Tóvári J; Döme B
    Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic chemotherapeutic agents.
    Schirner M
    Cancer Metastasis Rev; 2000; 19(1-2):67-73. PubMed ID: 11191065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Researchers target tumour blood vessels with antiangiogenic gene therapy.
    Frankish H
    Lancet; 2002 Jun; 359(9325):2256. PubMed ID: 12103296
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-angiogenesis drugs as a potential approach in cancer therapy].
    Sela B
    Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis inhibitors: what is the clinical future?
    Verheul HM; Pinedo HM
    Prog Drug Res; 2005; 63():67-91. PubMed ID: 16265877
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies.
    Narazaki M; Tosato G
    J Natl Cancer Inst; 2005 May; 97(10):705-7. PubMed ID: 15900035
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological parameters for the choice of antiangiogenic therapy and efficacy monitoring.
    Ziche M; Sorriso C; Parenti A; Brogelli L; Tricarico C; Villari D; Pazzagli M
    Int J Biol Markers; 1999; 14(4):214-7. PubMed ID: 10669949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors' do-it-yourself blood vessels.
    Leslie M
    Science; 2016 Jun; 352(6292):1381-3. PubMed ID: 27313019
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiangiogenic tumor therapy.
    Davis DW; McConkey DJ; Zhang W; Herbst RS
    Biotechniques; 2003 May; 34(5):1048-50, 1052, 1054 passim. PubMed ID: 12765031
    [No Abstract]   [Full Text] [Related]  

  • 14. Current strategies and future directions of antiangiogenic tumor therapy.
    Zhang ZL; Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer.
    Ebos JM; Quintela-Fandino M
    Curr Drug Targets; 2016; 17(15):1706. PubMed ID: 27109490
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-angiogenic therapeutic strategies and inhibition of tumor growth].
    Bachelot T
    Ann Pathol; 1999; 19(5 Suppl):S74-5. PubMed ID: 10599459
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges for imaging angiogenesis.
    Padhani AR; Neeman M
    Br J Radiol; 2001 Oct; 74(886):886-90. PubMed ID: 11675303
    [No Abstract]   [Full Text] [Related]  

  • 18. Abstracts of the 1st European Conference on Tumor Angiogenesis and Antiangiogenic Therapy. Munich, Germany, 1-3 October 2004.
    Angiogenesis; 2004; 7 Suppl 1():1-53. PubMed ID: 15505925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of angiogenesis in malignant tumors].
    Smolej L; Beneová P
    Acta Medica (Hradec Kralove) Suppl; 2005; 48(2):69-72. PubMed ID: 16922159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic therapy: it makes sense and is patient friendly.
    Kamen BA
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):571-2. PubMed ID: 16282885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.